Elabscience

DEAF1 Polyclonal Antibody

Product Code:
 
E-AB-16381
Product Group:
 
Primary Antibodies
Supplier:
 
Elabscience
Host Type:
 
Rabbit
Antibody Isotype:
 
IgG
Antibody Clonality:
 
Polyclonal
Regulatory Status:
 
RUO
Target Species:
 
Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
Shipping:
 
Ice packs
Storage:
 
-20°C
1 / 1
Immunohistochemistry of paraffin-embedded Human gasrtic cancer tissue using DEAF1 Polyclonal Antibody at dilution 1:40
❮❯

Immunohistochemistry of paraffin-embedded Human gasrtic cancer tissue using DEAF1 Polyclonal Antibody at dilution 1:40

No additional charges, what you see is what you pay! *

CodeSizePrice
E-AB-16381-20uL20uL£125.00
Quantity:
E-AB-16381-60uL60uL£172.00
Quantity:
E-AB-16381-120uL120uL£237.00
Quantity:
E-AB-16381-200uL200uL£344.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: China.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Abbreviation:
DEAF1
Background:
Suppressin, also known as DEAF1 (deformed epidermal autoregulatory factor 1), SPN, NUDR (nuclear DEAF-1-related transcriptional regulator), or ZMYND5 (zinc finger MYND domain-containing protein 5), is a transcription factor required for embryonic development. Suppressin contains one SAND domain and one C-terminal MYND-type zinc finger. It interacts with LMO4 and CLIM-2, suggesting that it plays a role mediating cell fate and embryonic pattern formation. Suppressin is expressed in a variety of tissues and localizes to the nucleus. Several isoforms exist due to alternative splicing and, depending on the isoform, Suppressin is secreted in some cell types. Secreted Suppressin can function to inhibit cell proliferation, arresting cells in the G0 or G1 phase. Mutations in the gene encoding Suppressin may result in a growth advantage leading to the development and progression of neoplasia. This suggest that Supressin is a potential target for cancer therapy.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Concentration:
1.4 mg/mL
Conjugation:
Unconjugated
Dilution:
IHC 1:50-1:200
Immunogen:
Synthetic peptide of human DEAF1
Purification method:
Affinity purification
Target Synonym:
Deaf1;DEAF1 transcription factor;DEAF1;Deformed epidermal autoregulatory factor 1 homolog;Nuclear DEA1 related transcriptional regulator;Nuclear DEAF-1-related transcriptional regulator;NUDR;SPN;Suppressin;Zinc finger MYND domain containing protein 5;Zinc finger MYND domain-containing protein 5;ZMYND5
UNIProt ID:
O75398

Documents